Table 1.
The function of miR-17-92 cluster and the relationship with cardiovascular disease.
| Cardiac parameter |
Effects of miR-17-92 | Target | Reference |
|---|---|---|---|
| Cardiomyocyte differentiation | Interference cardiac morphogenesis Promote differentiation |
T-box Isl1 |
[25] |
|
| |||
| Cardiomyocyte proliferation | MiR-19 promotes cardiomyocyte growth and proliferation | Wnt signaling pathway | [21] |
| Support proliferation of endothelial cells of cardiac blood vessels | MAPK, Elk-1 | [27] | |
|
| |||
| MI | Upregulate proliferation of cardiomyocytes, improve cardiac function, and reduce scar size | [21] | |
| MiR-19 protects ischemic injury | PTEN | [13] | |
| MiR-92a restrains endothelial cell angiogenesis | MKK4, KLF4 | [29] | |
|
| |||
| IRI | Resistance to apoptosis | MAPK/ERK, PI3K/AKT signaling pathway | [36] |
| MiR-19b alleviate apoptosis and improve survival of H9C2 cardiomyocyte | PTEN | [37] | |
|
| |||
| Aging | Inhibit aging process | Cdc42-SRF signaling pathway | [38] |
| Prevent cardiac fibroblast senescence | Par4-CEBPB-FAK signaling pathway | [39] | |